MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1371/journal.pone.0292106

Медицинская библиотека · PloS one · 2023

Identifying patients with multidrug-resistant tuberculosis who may benefit from shorter durations of treatment.

Winters Nicholas, Schnitzer Mireille E, Campbell Jonathon R, Ripley Susannah, Winston Carla, Savic Rada, Ahmad Nafees, Bisson Gregory, Dheda Keertan, Esmail Ali, Gegia Medea, Monedero Ignacio, Dalcolmo Margareth Pretti, Rodrigues Denise, Singla Rupak, Yim Jae-Joon, Menzies Dick

МетаанализСтатьяПеревод в очереди

Аннотация

OBJECTIVE

Studying treatment duration for rifampicin-resistant and multidrug-resistant tuberculosis (MDR/RR-TB) using observational data is methodologically challenging. We aim to present a hypothesis generating approach to identify factors associated with shorter duration of treatment.

STUDY DESIGN AND

SETTING

We conducted an individual patient data meta-analysis among MDR/RR-TB patients restricted to only those with successful treatment outcomes. Using multivariable linear regression, we estimated associations and their 95% confidence intervals (CI) between the outcome of individual deviation in treatment duration (in months) from the mean duration of their treatment site and patient characteristics, drug resistance, and treatments used.

RESULTS

Overall, 6702 patients with successful treatment outcomes from 84 treatment sites were included. We found that factors commonly associated with poor treatment outcomes were also associated with longer treatment durations, relative to the site mean duration. Use of bedaquiline was associated with a 0.51 (95% CI: 0.15, 0.87) month decrease in duration of treatment, which was consistent across subgroups, while MDR/RR-TB with fluoroquinolone resistance was associated with 0.78 (95% CI: 0.36, 1.21) months increase.

CONCLUSION

We describe a method to assess associations between clinical factors and treatment duration in observational studies of MDR/RR-TB patients, that may help identify patients who can benefit from shorter treatment.

Для цитирования: Winters Nicholas, Schnitzer Mireille E, Campbell Jonathon R, Ripley Susannah, Winston Carla, Savic Rada, Ahmad Nafees, Bisson Gregory, Dheda Keertan, Esmail Ali, Gegia Medea, Monedero Ignacio, Dalcolmo Margareth Pretti, Rodrigues Denise, Singla Rupak, Yim Jae-Joon, Menzies Dick. Identifying patients with multidrug-resistant tuberculosis who may benefit from shorter durations of treatment.. PloS one. 2023. DOI: 10.1371/journal.pone.0292106.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.